The Peter Attia Drive - May 03, 2021


#160 - Paul Offit, M.D.: The latest on COVID-19 vaccines and their safety, herd immunity, and viral variants

Topics
Hosted by
Mentioned
#159 - Peter Hotez, M.D., Ph.D.: Evolution of the anti-vaccine movement, the causes of autism, and COVID-19 vaccine state of affairs #161 - AMA #23: All Things Nicotine: deep dive into its cognitive and physical benefits, risks, and mechanisms of action

Episode Stats


Length

1 hour and 25 minutes

Words per minute

198.25

Word count

16,967

Sentence count

965

Harmful content

Misogyny

3

sentences flagged

Toxicity

2

sentences flagged

Hate speech

18

sentences flagged


Summary

Summaries generated with gmurro/bart-large-finetuned-filtered-spotify-podcast-summ .

In this episode, Dr. Paul Offit, co-inventor of the rotavirus vaccine, joins me to discuss the impact of the coronavirus outbreak in the United States over the past year, and what we can do to prevent similar outbreaks in the future.

Transcript

Transcript generated with Whisper (turbo).
Misogyny classifications generated with MilaNLProc/bert-base-uncased-ear-misogyny .
Toxicity classifications generated with s-nlp/roberta_toxicity_classifier .
Hate speech classifications generated with facebook/roberta-hate-speech-dynabench-r4-target .
Topics generated with Qwen2.5-3B-Instruct.
Hosts, guests, and mentioned names generated with spaCy (en_core_web_sm), reconciled against Wikidata.
00:00:00 Hey, everyone. Welcome to the drive podcast. I'm your host, Peter Atiyah. This podcast,
00:00:15 my website, and my weekly newsletter all focus on the goal of translating the science of longevity
00:00:19 into something accessible for everyone. Our goal is to provide the best content in health
00:00:24 and wellness, full stop. And we've assembled a great team of analysts to make this happen.
00:00:28 If you enjoy this podcast, we've created a membership program that brings you far more
00:00:33 in-depth content. If you want to take your knowledge of the space to the next level at
00:00:37 the end of this episode, I'll explain what those benefits are. Or if you want to learn more now,
00:00:41 head over to peteratiyahmd.com forward slash subscribe. Now, without further delay,
00:00:47 here's today's episode. I guess this week is Dr. Paul Offit. That may be a familiar name to
00:00:54 some of you because Paul was previously on the podcast in November of last year. At the time,
00:00:58 we spoke about the COVID-19 vaccines just prior to their first approvals. I wanted to have Paul back
00:01:04 to get an update on the vaccines and to get a sense of what the next year is going to look like.
00:01:10 As a refresher, Paul's a pediatrician specializing in infectious diseases and an expert on vaccines,
00:01:15 immunology, and virology. He is the director of the Vaccine Education Center and professor of
00:01:20 pediatrics in the Division of Infectious Diseases at the Children's Hospital of Philadelphia,
00:01:24 CHOP. And he is a professor of vaccinology at the Perlman School of Medicine at the University
00:01:30 of Pennsylvania. He serves on the FDA Committee for Biologics Evaluations and Research Vaccines and
00:01:36 Related Biologic Product Advisory Committee, evaluating not just the COVID-19 vaccines,
00:01:42 but vaccines for influenza and other infectious diseases. He is the co-inventor of the rotavirus
00:01:47 vaccine. In this episode, we start with an update of all four major classes of vaccines,
00:01:54 specifically talking about the two that are most utilized, which are the mRNA vaccines
00:02:00 and the adenovirus vaccines delivering DNA. We then talk about some of the safety concerns that
00:02:07 still remain around both of these. And Paul does a very eloquent job in my view of explaining
00:02:12 what is and is not a legitimate concern, both in the short term and the long term.
00:02:17 We talk about the variants and what the implications are of variants, and we get into
00:02:23 what herd immunity actually means. In other words, how much of it is going to require
00:02:29 a breadth of natural infection versus how much is going to require immunization. And we get into then
00:02:35 what's going to happen with respect to other populations being immunized, most notably people
00:02:41 under the age of 18. Something that I think many of you will find interesting in this discussion was
00:02:46 a deeper dive into the nature of immunology and how the short term immune response, usually mediated
00:02:53 by what's called the humoral system, differs from the longer term immune response, which we call the
00:02:58 cellular immune response, the memory immune response, how these two function together, and the
00:03:04 importance of the latter in providing durable immunity. We also talk a little bit about the origin
00:03:11 of this virus. I think there is a very interesting discussion around whether this virus originated in
00:03:18 a lab or it originated, quote unquote, naturally. And while a year ago, people who suggested it
00:03:24 originated in a lab were viewed as sort of conspiracy theorists, I don't think that's necessarily
00:03:29 the case today. And we talk a little bit about that. Finally, we talk about the future. I think most
00:03:34 people, Paul included, would agree that it is not a question of if, but rather when we see
00:03:39 another major coronavirus outbreak, given that this is the third one we've seen in 20 years,
00:03:45 what can we do to be better prepared for it? Neither of us pull punches on what we think went
00:03:49 wrong here. And most importantly, how would you need to remedy that in the future? So my hope is
00:03:55 that you'll find this podcast to be accretive to knowledge you've already gained through the recent
00:04:00 podcasts I've done on this topic, along with whatever else you're listening to on this topic. So
00:04:04 without further delay, please enjoy my conversation with Paul Offit.
00:04:12 Hey, Paul, it's great to have you back. Thank you so much for making time. Obviously, at the time
00:04:16 that we're recording this, I know you're busy with some news that we'll get to later. But nevertheless,
00:04:22 it seems like it's about the right time for us to pick up this discussion again, because the last
00:04:26 time we spoke, we were just on the cusp of watching a number of vaccines hit that first phase of early
00:04:33 use authorization. As we stand here today, I actually can't tell you the numbers, but
00:04:37 tens of millions of people have been vaccinated. And in some ways, there are still a lot of questions.
00:04:43 So let's start with just an update, the lay of the land for people. Broadly speaking, right,
00:04:48 four strategies, four scientific strategies in place to create vaccines. One of them is an mRNA vaccine,
00:04:56 which we'll talk about. The second, something that's a little more tried and true, at least
00:05:01 something that's been done a number of times before, using an adenovirus to deliver DNA. The
00:05:06 third is delivering directly purified protein of the virus. And the fourth, probably the oldest trick
00:05:12 in the book, is using live attenuated virus. Can you give us just a broad overview of where each of
00:05:20 those four are, and maybe what it says about the scientific challenges of the approval process for each?
00:05:27 At least in the United States, the messenger RNA vaccines are the farthest along. The FDA Vaccine
00:05:33 Advisory Committee approved the Pfizer messenger RNA vaccine on December 10th, the Moderna messenger RNA
00:05:39 vaccine on December 17th. And they then rolled off the assembly lines and into the arms of the American
00:05:46 public, such that now you have more than 120 million people who have received at least one dose of
00:05:51 an mRNA containing vaccine. So that's the farthest along, certainly in this country. In terms of the
00:05:57 adenovirus vectors, the replication defective adenovirus vectors, there's the replication defective
00:06:02 simian adenovirus vector, which is, that was put forward by the Jenner Institute at the University of
00:06:06 Oxford in the UK, that is partnered with AstraZeneca. And then the Johnson & Johnson product, which is
00:06:12 Janssen, that is the wholly owned subsidiary of Johnson & Johnson. And that's a replication defective
00:06:17 adenovirus type 26. The ad 26 vector had been used fairly extensively to try and slow the Ebola
00:06:24 outbreak in West Africa. So about 200,000 doses had been administered in West Africa of that vaccine.
00:06:30 Now we have more than 6 million doses of that that's been given in the United States. And then with
00:06:35 regard to the AstraZeneca vaccine, tens of millions of doses have been given in the United Kingdom as well
00:06:39 as in Europe. Certainly more than 20 million doses overall have been given of that vaccine.
00:06:44 In terms of the purified protein vaccine, probably the company that's the farthest along is Novavax.
00:06:51 They use a bacalovirus expression system. So basically you have a bacalovirus into which you
00:06:55 insert, in this case, the gene that codes for the coronavirus spike protein, and that's grown up into,
00:07:01 in butterfly cells, basically, spedoptera, fruggy peridocels. It's the exact same way we make flu
00:07:06 block. So there's a lot of experience using that technology to make a vaccine. Those studies have been
00:07:12 largely completed, but Novavax has been fairly slow to gain any sort of approval yet, to my knowledge,
00:07:18 anywhere yet. Live attenuated viral vaccines, they're still in the works. I don't know of any
00:07:23 live attenuated viral vaccine that is now being routinely given to anybody in any country in this
00:07:28 world, but I could be wrong. I haven't heard that. I know people were working, a number of
00:07:31 groups working on it. And then there's the whole killed viral vaccine, which is the product that's
00:07:36 used by China, which has been extensively given to now, again, tens of millions of people, which is
00:07:41 the way that we make the polio vaccine, the inactivated polio vaccine, or the hepatitis A
00:07:44 vaccine, or the rabies vaccine. So again, a lot of experience with that product. There's some
00:07:49 question about how effective it is. I should also add that the Russian vaccine is also a replication
00:07:53 defective adenovirus vaccine. In that case, AD26, human AD26, followed by human AD5. So those are the
00:08:00 strategies that are currently wending their way through the world.
00:08:03 And is it safe to say, Paul, that the whole killed is probably, I actually mistakenly said
00:08:09 that the attenuated, because I tend to lump that in with whole killed, but really whole killed is the
00:08:14 first play that's really initiated vaccination. Is that kind of the oldest trick?
00:08:20 Well, the oldest, oldest trick is a live non-human virus. I mean, the cowpox was the first vaccine in
00:08:26 the late 1700s. So basically, the thinking there was that, not that it was thinking at all,
00:08:30 since this was the late 1700s before we actually knew what viruses were. I mean,
00:08:34 it was just phenomenology. But now we know that the cowpox virus is antigenically related close
00:08:40 enough to human smallpox that immunization with one can protect you against disease caused by the
00:08:44 other. But you're right, the second strategy was the whole killed virus strategy. That was 100 years
00:08:49 later in the late 1800s in France with Louis Pasteur making the whole killed rabies virus.
00:08:55 For rabies, right?
00:08:55 Yeah, that's right.
00:08:56 Yeah. I remember my mom reading me that story when I was a little boy, actually. I could listen to that
00:09:02 story every single night because it had pictures of him taking the serum from the dog and killing the
00:09:09 virus and giving it to the boy. I can still actually see every part of that book. You know,
00:09:14 one of the things that I hear a lot of is that MRNA thing is crazy. This is totally sci-fi. It's
00:09:21 completely experimental. Why would anyone subject themselves to something that is so risky and so
00:09:27 unproven? A little while ago, I wrote something on this topic trying to make the point, I don't know
00:09:33 how convincing it was, that actually it's not as experimental as people think and that this
00:09:37 technology has been around for decades, plural, and that the only thing that's new is that this is the
00:09:44 first time the final step has been made, which is actually taking a virus that is of concern to
00:09:50 humans, sequencing it, and then putting it into a clinical practice. But this notion of using MRNA,
00:09:57 this didn't just come out of nowhere. This wasn't something that was developed in 12 months,
00:10:01 as one might believe if they weren't really following the science too closely.
00:10:05 Do you find yourself confronted with the same type of question?
00:10:08 Yes. And they're a reasonable question. It is a new era of vaccinology. I mean,
00:10:12 we just went through that briefly, but it's arguably the fifth era. I mean, you go to
00:10:16 initially sort of animal strains that are related to humans, then you go to the inactivated vaccines,
00:10:20 then you go to the live attenuated viral vaccines, then you go to purified protein vaccines. What all
00:10:26 those four strategies have in common is that you're giving the viral protein that you're interested in.
00:10:30 I mean, in this case, we're interested in the SARS-CoV-2 spike protein. And when you give that
00:10:34 protein in one form or another, whole virus or live attenuated virus, or just purified protein itself,
00:10:40 you're giving that protein, the viral protein, then the person makes an antibody response to that protein.
00:10:45 You're not doing that here. You're giving the gene that codes for the viral protein,
00:10:49 that's translated in the cytoplasm to the viral protein. So your body makes the viral protein,
00:10:54 then your body makes an antibody response. And you can see why people are concerned, because it's the term
00:10:59 that is used correctly as it's a genetic strategy. You're giving a gene. And the minute you say that
00:11:04 to people, that's often interpreted as something that could interfere with your genes or reorient
00:11:09 or re-engineer your genes. That's the way people hear that. They hear it as gene therapy. And in
00:11:13 a sense, it is kind of gene therapy, but not in the more traditional way that it's meant.
00:11:17 What is the best answer you have to someone that says, look, I'm not worried about acute toxicity
00:11:25 toxicity. Because given how many tens of millions of people have received both the Moderna vaccine and
00:11:34 the Pfizer vaccine, I think anybody can say unequivocally, there can't be any complications
00:11:41 in the short run that are clinically relevant. I mean, we just, there've been too many people
00:11:46 vaccinated to know that, oh my gosh, you know, 0.001% of people are going to suffer some horrible
00:11:52 complication. But it's not necessarily clear that there can't be some really long-term
00:11:58 complication that doesn't show up for a year or two years or three years. And therefore,
00:12:03 I think to your point, it is a reasonable point of concern to say, well, this is still very new,
00:12:11 and we don't have 10 years of data the way we would if this strategy were deployed through a
00:12:17 traditional non-emergency use approach for something like influenza, where we didn't have to rush,
00:12:23 because we have so many other strategies. So my question is, what would you say to reassure somebody
00:12:29 that in five years, we're not going to learn something horrible about inserting coronavirus
00:12:35 mRNA into our cells? All right, so there's two ways I would answer that. The first is,
00:12:41 can the messenger RNA in any way alter our DNA? Because I think that's at the heart of what people are
00:12:47 worried about, and then that comes up later in some form or another. That's not possible for
00:12:52 three reasons. First of all, when the messenger RNA is taken up by cells in our body, it's primarily
00:12:57 something called dendritic cells, which is the major antigen presenting cell in your body that presents
00:13:01 cells, presents antigens to the immune system, to the rest of the immune system. So it's taken up,
00:13:06 it's in a lipid nanoparticle, the lipid nanoparticle is taken up in the cell, it's stripped away,
00:13:10 and then that messenger RNA enters the ribosomal system, where like the other couple hundred
00:13:14 thousand copies of messenger RNA that are in your cytoplasm, it's then translated to a protein.
00:13:19 And that happens over days. And then the messenger RNA, like all messenger RNAs, breaks down and is no
00:13:25 longer making that protein. So the question then is, can the messenger RNA get into the nucleus and
00:13:30 in any way alter the DNA, which it cannot do for three reasons. First of all, it has to be able to
00:13:35 cross the nuclear membrane, which requires a nuclear access signal that it doesn't have.
00:13:39 Secondly, even if it got into the nucleus, it's RNA, it's not DNA. So in order to affect DNA,
00:13:46 it has to be converted to DNA, which requires an enzyme like reverse transcriptase, which it also
00:13:51 doesn't have. Even if it was converted to DNA, which it can't because it can't cross the nuclear
00:13:56 membrane and it can't be basically reverse transcribed back to DNA, it still has to insert
00:14:00 itself into the DNA, which requires an integrase enzyme that it also doesn't have. So it's not
00:14:06 possible. You have a better chance of developing x-ray vision after you've gotten this than you
00:14:11 have of the mRNA in any way altering your DNA. Although I never understand why people, when
00:14:15 they say that it alters your DNA, doesn't think it can alter your DNA for the good, you know,
00:14:19 like making you Spider-Man, for example, or something like that. People never talk about that.
00:14:23 So that's one thing. I think that's not possible. The second thing is long-term effects. I guess I
00:14:28 would challenge, we have these discussions at the CDC a lot with people who have a lot of experience with
00:14:33 this. Name that serious adverse event that's associated with vaccines that has not been
00:14:38 picked up within two months of getting a dose. And there are. I mean, you know, vaccines like
00:14:42 any medical product that have a positive effect can have a negative effect, including a severe negative
00:14:46 effect. And so, for example, the squalene adjuvanted influenza vaccine that was used in Europe
00:14:52 for the 2009 pandemic, one of those vaccines, so-called Pandemrix, could actually cause narcolepsy.
00:14:58 I mean, it was rare. It was about one per 55,000 people, but it was real. And it, again,
00:15:02 occurred within six weeks of getting a dose. The oral polio vaccine that was created by 0.93
00:15:07 Albert Sabin to basically eliminate a polio from this country could itself cause polio.
00:15:11 It could actually revert to essentially neurovirulent or wild-type virus and cause polio again,
00:15:16 what happened within a few weeks of a dose. The influenza vaccine is a rare cause, roughly one
00:15:21 per million. And for polio, it's about one per 2.4 million doses. But influenza, about one
00:15:25 per million doses, can cause Guillain-Barre syndrome, which is an ascending paralysis,
00:15:30 which can be severe and occasionally fatal. Again, occurs within six weeks of a dose.
00:15:34 The yellow fever vaccine, in roughly one per million people, depending on which strain you use,
00:15:39 can cause something we call viscerotropic disease, which is a nice way of saying yellow fever. I mean,
00:15:44 the yellow fever vaccine can cause yellow fever, much the same way the oral polio vaccine could cause
00:15:48 polio, again, within a week or so of getting the dose. So I don't know of that serious side effect that
00:15:54 causes long-term problems. Now, it is true that some of these, most of these side effects,
00:15:57 all of these side effects are so rare that when they occur, they only occur when they're in
00:16:02 tens of millions of people, and then you can see that. But that's why for every vaccine,
00:16:06 you have to wait for two months after the second dose or whatever the last dose is to make sure
00:16:11 it's still safe. And that was true of all these vaccines going out. I mean, we're going to get to
00:16:14 the issue, I think, later in this broadcast with Johnson & Johnson vaccine. But again, that issue came
00:16:19 up within two weeks of a dose. Yeah. I just want to make sure that for
00:16:23 the listener, we really highlight the salient point here, which I think is actually the first
00:16:27 point that you made. Because I do think that for most people who are, I think, hearing a lot of
00:16:34 misinformation, it's coming through the channels of people who don't really understand enough biology
00:16:41 to sort of explain exactly how messenger RNA is translated into protein. And of course,
00:16:49 that's what we want here. And how we don't have any of the machinery to enable the reverse.
00:16:56 Let's talk a little bit about HIV as a virus, because HIV actually can undergo some of this process.
00:17:03 So maybe use HIV as a counterpoint. And also, let's dovetail that into how failed attempts
00:17:10 to create a vaccine for HIV. Why is that not possible? And what has that taught us about
00:17:16 the current strategy here? A lot packed into that question, I realize.
00:17:19 Yeah. I would say if I had to pick what I think is the most heinous virus that was ever created,
00:17:24 it would be HIV. Because it does two things. First of all, when you're first infected with
00:17:29 human immunodeficiency virus, and it begins to reproduce itself, you make an antibody response to that
00:17:34 virus that neutralizes and kills that virus. It does. It kills it effectively, efficiently.
00:17:40 But what happens is it continues to evolve during a single infection so that the surface protein,
00:17:47 the so-called glycoprotein of that virus, to which you make an antibody response to prevent
00:17:51 the virus from binding itself, continues to mutate again and again and again. Here we talk about how
00:17:56 influenza virus, for example, mutates so much from one year to the next that natural infection or
00:18:02 immunization from the previous year does infect you, hence the need for a yearly vaccine. This
00:18:06 virus does that during a single infection. It just continues to mutate and mutate and mutate and mutate,
00:18:12 number one. Number two is, where does it grow? It reproduces itself primarily in something called T
00:18:17 helper cells, which is the major orchestrator of your immune system. It's T helper cells that help
00:18:22 B cells make antibodies. It's T helper cells that help stimulate cytotoxic T cells, which kill virus
00:18:28 infected cells. So it paralyzes the orchestrator of your immune system at the same time that it
00:18:33 continues to mutate so that your immune system never catches up to it. It is a remarkably effective
00:18:39 virus at being able to kill us. I mean, we have, you know, in the late nineties, we had finally
00:18:44 developed a highly active antiretroviral therapy as a treatment. So we were able to do what we wanted
00:18:49 to do, which was to make HIV a chronic disease. But that vaccine has remained elusive and it is not
00:18:55 because of lack of money or lack of effort. I know Merck put several billion dollars into that project
00:19:02 and was unsuccessful, again, with actually with a adenovirus vector into which they then inserted
00:19:08 either the group antigen or the envelope protein or the glycoprotein genes. And it didn't in any sense
00:19:14 work. In some ways it was actually worse for those who were vaccinated. Yeah. I used to sort of explain
00:19:19 it to people as, imagine you were up against a foe, you know, an army was up against another army
00:19:27 and the army knew how to strategically target the general. I mean, and the general being the CD4 cell, 0.92
00:19:35 the helper T cell. And all of a sudden you could just sort of abolish any chance of there being a
00:19:40 coherent strategy to fight back. But you're right, that those two things, the constant mutation
00:19:46 and the ability to infect, again, at least if you come at this from the cellular side,
00:19:50 the most important cell in the arsenal is pretty remarkable. What is it about those failures that
00:19:56 maybe actually sped up the development of vaccines against SARS-CoV-2, if anything?
00:20:02 No, I think you always learn. I mean, the replication defective adenoviruses that were used,
00:20:08 it was an adenovirus human serotype five that was used in the Merck trial. Certainly we learned about
00:20:13 replication defective adenoviruses for the Ebola vaccine, not only the J&J vaccine, but also there
00:20:18 was a replication competent of viral vector using something called vesicular stomatitis virus,
00:20:24 which is sort of a cousin in many ways of rabies, but obviously doesn't cause any of the symptoms
00:20:29 of rabies or symptoms at all. So yeah, sure. I mean, we've learned as we've gone here and with HIV,
00:20:36 it's like Jonas Salk's strategy was to try and take the whole virus and kill it. That obviously was never
00:20:40 going to work. That was the strategy he had used. He thought it could apply to other things that
00:20:44 clearly doesn't apply here. That vaccine has failed and failed and failed. I put that sort of in the
00:20:49 same category as like the universal flu vaccine. I mean, it's not for one of money and is not for
00:20:54 one of effort. I trained in a flu lab actually in the early 1980s at the Wistar Institute here in
00:20:58 Philadelphia. I was working on rotoviruses, but I was trying to make monoclonal antibodies to
00:21:02 rotavirus surface proteins. And I was learning to do it in a flu lab. And it was just these brilliant
00:21:07 researchers, you know, people like John Udell and Walter Gerhardt and Lew Stout all in one place.
00:21:11 I don't think I realized how lucky I was at that time to be around such amazing scientists. But
00:21:16 the head of that lab at the time said something to me I'll never forget. And now 40 years later,
00:21:20 it's still true. He said, quote, if you want to research career that lasts for the rest of your 0.90
00:21:25 life, study influenza. I think that's a virus where it's going to take a long time to catch up to.
00:21:30 So let's actually talk a little bit about influenza because there's something sort of strange about
00:21:36 this coronavirus that fits in between the one and done viruses and influenza. And let's just put HIV
00:21:44 in its own category because I think you've appropriately described it as the single worst
00:21:49 virus that's ever been shat into the civilization of mankind. I mean, it is truly, fortunately,
00:21:55 an anomaly with regard to how difficult it is. But on the one end of the spectrum, you have influenza,
00:22:00 which has so much genetic drift that every year you have to get a new vaccine if you want to have
00:22:09 any chance of being vaccinated. Of course, you could say, I don't want to be vaccinated because,
00:22:14 you know, it's generally not a very lethal virus, but it's bad enough. And certainly in high risk
00:22:18 populations, a vaccine makes a ton of sense. But, you know, we can't hold our natural immunity to it
00:22:24 from year to year to year. At the other end of the spectrum, you have polio, smallpox,
00:22:31 pertussis, pick your favorite of these things where they don't seem to mutate. Or if they do,
00:22:37 I shouldn't say they don't seem to mutate. Whatever mutations they have don't seem to impact
00:22:43 our body's immune system from reacting to them. So far, am I correct on those two ends of the spectrum?
00:22:50 Yes. Okay. Now we have this coronavirus, which seems to be neither of those. It's not clear that
00:22:58 it has the genetic drift of an influenza, where every year it's basically a new virus. But it also
00:23:04 appears that it ain't one of the other guys too, where you're going to be one and done strategy with
00:23:09 your vaccine. In fact, even though B117 looks like it is going to be managed through current
00:23:18 vaccination strategies, it is not clear that the South African variant, the South American variant,
00:23:24 Brazilian variant, are going to respond in that way, given significant changes in their binding
00:23:30 properties. What does that say about this virus, if anything? Or is that simply just the luck of the
00:23:35 biologic draw? Right. So I'm not sure I can explain why these viruses act the way they act. But your
00:23:42 assessment was exactly right. And on the one hand, once at the end of the spectrum, you have flu,
00:23:46 which you said correctly, year to year, probably you could argue minute to minute. I mean,
00:23:53 I'm on the FDA's vaccine advisory committee. The first week in March, we always pick flu strains.
00:23:57 And the way that works is we, the Department of Defense, the World Health Organization,
00:24:01 the CDC, all present data about these flu strains that are circulating in all areas of the world.
00:24:07 So we can see how these clades of influenza and subclades and sub-subclades are constantly sort of
00:24:13 moving around so we can try and predict which strains to include. And we certainly work hard to
00:24:18 try and get the strains right. We usually get them right, but it's amazing we get them right, given how
00:24:23 much this virus mutates. And flu is a single-stranded RNA virus. Therefore, like all single-stranded RNA
00:24:28 viruses, its replication isn't highly faithful. But then you have a virus like measles, which is
00:24:33 also a single-stranded RNA virus, which also mutates, but mutates in such a confined way
00:24:38 that the vaccines that you introduced or we introduced in the early 1960s continue to work.
00:24:43 Now, you know, 50 plus years later, that virus has never mutated away from the vaccine, even though
00:24:48 it is also a single-stranded RNA virus. So then you have this virus, also the SARS-CoV-2 virus,
00:24:53 also a single-stranded RNA virus, and also does mutate, but much more slowly actually than
00:24:58 influenza. And in many ways, in a manner that is between those two, between, say,
00:25:04 measles and influenza. So it does mutate, all for the purpose primarily of becoming more contagious.
00:25:09 That's really the main goal of viruses is to continue to reproduce themselves. They don't
00:25:13 necessarily want to make themselves more virulent, more likely to kill you because then they can't
00:25:17 reproduce anymore. So they really, their goal is to be more contagious. So the bat virus, which was 1.00
00:25:21 largely a bat virus that sort of first started in China and swept through China, was not the virus
00:25:26 that left China. The virus that left China was the first variant, the so-called D614G variant.
00:25:30 That was the first variant. That's the virus that swept through Europe. That's the virus that swept
00:25:34 through the United States. That's the virus that's killed 570,000 people. That's the virus to which all
00:25:39 vaccines are made to try and prevent the D614G strain. But now these other variants come up. You know,
00:25:45 the B117 UK variant, the Brazilian variant, the South African variant, now the New York variant,
00:25:50 the California variant. So there's always going to be variants that are made as the virus tries to be
00:25:54 more contagious. And so the critical question then is, to what extent will it drift away from
00:25:58 immunity caused by vaccination? And the answer so far is that the B117 is close enough to that
00:26:04 initial virus, the left China, the D614G variant, that immunization with one protects against the other
00:26:10 well. I mean, really well. They're close enough where there's not really a critical immunological
00:26:16 distinction between those two viruses. But the South African and Brazilian strain, now the New
00:26:20 York strain, all the so-called variants of concern are different, but not so far critically different
00:26:27 in this sense that I think natural infection or immunization still protects against severe
00:26:33 critical disease, meaning still protects against hospitalization and ICU admission and death.
00:26:38 That's still true. When we've crossed the line with these variants is when you see,
00:26:43 when you see, and we haven't seen this yet, people who are either naturally infected or fully immunized
00:26:48 that nonetheless are hospitalized or killed by a variant virus. That line hasn't been crossed yet.
00:26:52 Now we're looking because now as people are getting hospitalized and dying of this virus,
00:26:57 we always have to look at the virus they're getting infected with. And there's an NIH group that's
00:27:01 specifically designed to do that, to make sure that we have, these people aren't being infected with
00:27:06 variants and they're critically different that now you're not even protected against severe critical
00:27:11 disease. How do we know in the situation you just described where someone who's been previously
00:27:16 infected or vaccinated becomes infected with a variant of concern and goes on to have a bad adverse
00:27:22 outcome, either ICU and or death, how do we know that it's because their existing immunity was
00:27:29 incapable of responding versus they simply had lost immunity? Are you also checking for some
00:27:35 quantitative or qualitative assessment of their existing immunity?
00:27:40 What you can say, if you isolate a virus, sequence it and realize it is just the D614G strain or the
00:27:46 B117 strain, something that should have been fully susceptible to immunity induced by natural
00:27:50 infection or immunization, then one of those two things is true. Either you had an adequate immune
00:27:54 response and lost it, or you never really developed an adequate immune response. I'm not sure how easy
00:27:59 those two things would be to figure out at that point.
00:28:02 Right. It's tough to distinguish those two.
00:28:03 Yeah. That's the issue.
00:28:05 Right. But then what happens if they are confronted with the Brazilian variant? How will we know if
00:28:14 indeed it's the latter problem, which you just described, or frankly, the more frightening problem,
00:28:21 which is actually no amount of current immunity either acquired from D614 or through any of the
00:28:28 vaccines is going to save you. And basically we are back to square one of a pandemic.
00:28:33 Right. So I think when we isolate those variants, the question is, you take it to the laboratory and
00:28:39 see whether or not then the number of mutations that have occurred have occurred to the point that when
00:28:45 you take sera from people who are adequately immunized or people who are naturally infected,
00:28:49 that it doesn't neutralize that virus in the lab. I mean, that'll be the first clue that it's now
00:28:54 escaped recognition by natural or vaccine induced immunity.
00:28:57 And we're confident that an in vitro assay to look at neutralizing antibodies in the presence of
00:29:03 a new variant is pretty sufficient to give us that insight. We won't have to rely on epidemiology to
00:29:09 give us the answer.
00:29:09 No, I think it's pretty sufficient. I mean, it does ignore T helper cell responses, which tend to be
00:29:15 broader and are of value in that they do offer that sort of broader immunity where even though
00:29:20 there have been mutations in the receptor binding domain or the interminal domain, that you still
00:29:24 would get some evidence of immunity. That's why T helper cell responses are so critical here.
00:29:30 But no, I think we can figure, for the most part, figure that out.
00:29:33 Okay. So the good news about what you're saying, Paul, is you're holding us to a higher and more
00:29:38 conservative standard? Because what you're basically saying is I can test in vitro what a B cell can do
00:29:45 through neutralizing antibodies. I can't test what a T cell can do, but if it passes the B cell test,
00:29:50 I don't need to worry about it. Now, if it fails the B cell test, we still don't know about the T cell
00:29:56 test and that can only be played out in the real world. But if it's failing the B cell test, we're going
00:30:02 to take action. Presumably, we're not going to wait and assume that this is going to be worked out on
00:30:07 the side of T cells. I think that's right. I mean, I think that's right. Yeah. I mean,
00:30:11 if you look at the work that was done by Shane Crotty and others in La Jolla, looking at people
00:30:15 who are naturally infected and then, you know, if we're exposed to a virus again, we're protected.
00:30:20 They did find that while antibody responses fade over time and can fade over five, six, seven months
00:30:26 later, that memory B cells are still there and memory T helper cells or memory cytotoxic T cells are
00:30:32 there. And that's good. Now, you know, you have, this is a virus that has an incubation period of around
00:30:36 six days, meaning from the time you're first exposed to when you develop symptoms is about
00:30:40 six days. That's between sort of the typical mucosal infection like rotavirus or influenza,
00:30:46 where incubation periods are very short, one to two days, and a virus like measles or German measles,
00:30:51 which have, or chicken pox, which have incubation periods of 10 to 14 days.
00:30:55 The longer incubation period diseases are better in the sense that you really can induce
00:31:00 sterilizing immunity and therefore you really can eliminate those viruses. We eliminated measles from
00:31:04 this country by the year 2000. We eliminated rubella from this country by the year 2005.
00:31:09 The only reason measles has come back is because a critical number of parents have chosen not to
00:31:12 vaccinate their children, but those are eliminatable viruses. This is not because it's virus in the
00:31:19 bloodstream is not an important part of pathogenesis. So when you have long incubation periods, all you
00:31:24 need is immunological memory because there's plenty of time for activation and differentiation of
00:31:27 memory B cells to become effector cells, meaning antibody producing cells, and therefore you're good.
00:31:31 For the shorter incubation periods, your hope is to modify disease. Because a disease like rotavirus,
00:31:37 which has an incubation period of two to four days, you can stimulate then those memory cells,
00:31:41 which are long lived to become antibody producing cells, but you've already started to sort of
00:31:46 replicate because the incubation period is so short and it takes about three to five days to get
00:31:49 activation and differentiation of memory cells. So when incubation periods are short,
00:31:53 the best you can hope for is to modify disease associated with infection. So that's true of flu,
00:31:57 it's true of respiratory disease. Incentral virus is true of rotavirus. For measles, on the other hand,
00:32:02 where you have this long incubation period, as long as you have memory cells, which are generally
00:32:06 long, you have plenty of time for activation and differentiation of those cells to become
00:32:10 antibody secreting cells. And that's why you can eliminate those diseases. This is actually somewhere
00:32:14 in between. It's about a six-day incubation period. So, and again, virus in the bloodstream is really
00:32:20 not an important part of pathogenesis, so IgG memory cells become a little less important. But I do think
00:32:26 that we can control this infection. But I think that like all mucosal infections, your two choices,
00:32:31 basically, as we move forward are immunization or natural infection. Those are your two choices.
00:32:36 So, Paul, that's actually an amazing insight about how the SARS-CoV-2 has that sort of gestation
00:32:43 period that puts it into kind of an intermediate zone between the short and the long. Maybe let's
00:32:50 take a moment to just explain to people how the cellular immune system comes into play here. So,
00:32:56 I think by this point, folks who have been paying attention to this understand how the neutralizing
00:33:01 antibodies can work on first contact and how that can provide immunity in the weeks and months
00:33:08 following an infection. But to your point, at some point down the line, call it six months later,
00:33:14 12 months later, a year later, or whatever, 18 months later, those neutralizing antibodies may not
00:33:20 be there in sufficiently high enough titers. What is the actual process by which that virus now gets
00:33:27 presented to the cellular immune system such that we can re-engage B cells to come out and make more
00:33:35 neutralizing antibodies under the instruction of T cells? Maybe walk people through how
00:33:39 that works through antigen presentation, et cetera. The virus would be then picked up by
00:33:44 major antigen presenting cells in the body, like dendritic cells, macrophages, and to some extent,
00:33:49 B cells, broken down into small sort of 10 to 15 mer peptides put on the surface of the cell of these
00:33:56 antigen presenting cells. And then they travel to T helper cells where they then stimulate T helper cells to
00:34:01 do two things. One is to stimulate B cells to make antibodies. Two is to stimulate cytotoxic T cells to
00:34:07 kill virus infected cells. But as long as you have immunological memory, as long as you have memory
00:34:12 B cells, memory T helper cells, memory cytotoxic T cells, and those are generally longer lived, then you
00:34:19 can at least have activation and differentiation of those memory cells to become effector cells in the
00:34:24 case of B cells, antibody producing cells. In the case of cytotoxic T cells, T cells that kill virus
00:34:29 infected cells. So memory is what you want. And I think, I guess I was encouraged by the work of
00:34:35 Shane Crotty and others that memory cells here do, at least after natural infection, appear to be
00:34:39 fairly long lived. I'm also encouraged by the messenger RNA data, where after that second dose,
00:34:45 you clearly get stimulation of T helper cells and cytotoxic T cells, which suggests that you'll have
00:34:51 also somewhat longer lived responses. I mean, I'd like to think that these responses would be durable
00:34:55 enough after natural infection or immunization to protect you for a couple years, three years,
00:35:01 four years. I'd like to think that's true. I mean, we'll see whether or not it ends up being true.
00:35:05 But the good news about the mRNA strategy is it's a powerful immunization. I mean, I'm amazed at how
00:35:12 effective it is. And one thing that the people at least can notice is that many people get shots in
00:35:17 their arms for a variety of vaccines. This vaccine often causes lymph node enlargement under your arm,
00:35:23 so-called ipsilateral lymphadenopathy. That's not common. You see it with the smallpox vaccine,
00:35:29 which is another powerful immunogen. And you see it with this vaccine. Those antigen presenting cells
00:35:34 travel to the local lymph node and then stimulate that response to the extent that your lymph node
00:35:38 actually enlarges. It is a powerful immunogen, these mRNA vaccines. It's so funny that you bring that up,
00:35:44 Paul. I was going to bring that point up later. So both my wife and I had whole body MRIs. We do this
00:35:49 every once in a while for sort of a cancer screening protocol. And we had them four days ago. And the
00:35:55 radiologist said, hey, I assume you guys have been vaccinated. And we said, yep, both vaccinated
00:36:02 at such and such a time. He said, okay, let me show you something on the MRI. The radiologist is a very
00:36:06 close friend. And he said, look at the extent of lymphadenopathy under your arms. This is normally
00:36:12 something that in a case of a woman would make me think she potentially had breast cancer. 1.00
00:36:17 That's how inflammatory, how concerning these nodes are. He said, look, I've now looked at enough
00:36:23 of these in the past couple of months to realize that it's almost always people responding to the
00:36:27 vaccination of this virus. And he said he is seeing it more with the RNA viruses, the Moderna and Pfizer.
00:36:36 I didn't ask, and I should have asked, to what extent is he seeing it with the adenoviruses?
00:36:41 But I think what you said is very interesting. And I only knew of it literally four or five days ago.
00:36:46 I want to ask you another question about this, which is, why is it that the J&J
00:36:50 virus is able to provide such a benefit after only one injection, whereas the RNA viruses needed that
00:36:57 second injection? Right. And if you look at these replication-effective
00:37:00 similar human adenoviruses, the J&J vaccine, the replication-effective AD26, human adenovirus 26,
00:37:06 they induce cellular immunity after a single dose. That's really not true with the mRNA vaccines.
00:37:10 You need that second dose. I'm not sure why one is more powerful in terms of one dose versus two doses,
00:37:15 but that is true, which is why it's all the more important to get that second dose of mRNA vaccine.
00:37:20 There are a lot of people, people who I actually really respect and are well-known in the field of
00:37:26 epidemiology or virology, who have written op-ed pieces that have gotten a lot of national play
00:37:32 on why it is that one dose of mRNA vaccine gives you 80% effective protection, whereas the second dose
00:37:37 gives you 90% or 95%, and that let's get as much first dose out there as we can. I think as long as
00:37:43 people realize you need that second dose, I mean, I just worry that people are going to hear, well,
00:37:48 80% protective after one dose, 90% after two doses. That's not that big of a deal. I know that with
00:37:54 the second dose, there's more side effects, so I'm just going to go with one dose, and then confuse
00:37:58 it with the fact that J&J's vaccine, Johnson & Johnson's vaccine is one dose. This is a two-dose
00:38:03 vaccine, the mRNA vaccines, and the choice not to get that second dose is a choice probably to get less
00:38:08 durable immunity, less pleat immunity, and likely less effective immunity against these variants that
00:38:14 have drifted farther away from the original strain. One other point on that, Paul, that I think is a
00:38:20 real mistake that the press has made, and frankly, I think that the vaccine companies have made,
00:38:25 is they have not communicated clearly the difference between relative risk reduction and absolute risk
00:38:31 reduction. So when the J&J vaccine received its emergency use authorization, I think the headline
00:38:37 grabbing statement was, hey, we just heard that Pfizer is 96% effective and Moderna 95% effective,
00:38:46 but J&J looks like it's only 66% effective. Those numbers are probably off by a couple of percent,
00:38:52 but directionally, they are correct. And at the surface, you would say, why in the world would
00:38:57 you take the J&J vaccine, even though it's only a single shot? Or you might ask another question,
00:39:02 which is, well, what happens if you took two shots of the J&J? Wouldn't that put it on par,
00:39:06 et cetera? And it turns out, I actually had to go back and look at the data to actually see what the
00:39:13 true risk reduction was. Now, I won't go into it here for people because it would take too long,
00:39:17 but we'll link to it in the show notes. We have an entire post I've written about the difference
00:39:22 between absolute risk reduction and relative risk reduction. But you must talk about this in terms of
00:39:27 absolute risk reduction. And when you look at the absolute risk reduction, it turns out that the J&J
00:39:33 vaccine has a 1.7% absolute risk reduction versus a 1.2% absolute risk reduction for Moderna. And I
00:39:42 believe Pfizer is actually less than 1% risk reduction. These are all great vaccines,
00:39:48 but it turns out that J&J gets the most bang for its buck. Now, I wanted to talk with you about why
00:39:54 you think there is that discordance between the lowest relative risk reduction in the mid-60s and
00:40:00 the highest absolute risk reduction, which is the number that matters, approaching 2%. Do you believe
00:40:05 that the Pfizer and Moderna vaccines were tested on less susceptible populations and that J&J was
00:40:12 just tested on a sicker population that was therefore going to benefit more greatly?
00:40:16 Well, so there are different strategies. So it is interesting how both mRNA strategies had very
00:40:21 similar, at least relative risk reduction. But you're right. I mean, it is interesting how
00:40:26 we don't talk about it that way. We also don't talk about that way with regard to safety issues.
00:40:30 So if you look, for example, I'm trying to remember the specific numbers for the Pfizer trial,
00:40:33 but there were like 165 cases of disease in the placebo group and like eight cases in the vaccine
00:40:40 group. So that's 165 cases per, in the case of the Pfizer trial was a roughly 40,000 person trial.
00:40:47 So you're roughly, it's like 165 cases, you know, per 20,000 people that got placebo as compared to
00:40:53 like eight cases per 20,000 people who got the vaccine. So when you actually divide that all up,
00:40:58 the absolute difference is much less dramatic than is, you know, the sort of the relative risk.
00:41:03 Right. The Pfizer absolute risk difference was like 0.9%. And you're right. The total number of cases
00:41:10 was about 170 total cases in 20,000 or 40,000. I'm sorry. But you're right. The difference was
00:41:20 eight versus like 165 or something like that. Right.
00:41:23 Which again, makes me just think like, these are people who were either less exposed,
00:41:27 more healthy. There was something in these populations that differed dramatically from the
00:41:33 J and J population where, I mean, we're talking about 500 infections versus a hundred infections
00:41:40 directionally. So the relative reduction wasn't as high, but the absolute reduction, like I said,
00:41:45 1.7%, which we're going to come back to in a moment. It's worth keeping in the back of your mind.
00:41:50 When you have a 1.7% absolute risk reduction, that means your number needed to treat to prevent
00:41:59 a negative, a bad outcome is very low. I mean, we're talking about what, 60 for an NNT?
00:42:05 No, you're right. It's interesting that, I mean, the way I think of it, just because it's easier for
00:42:11 me to conceptualize it, is if I walk on the street in front of my house, I have a certain risk of being
00:42:16 hit by a car, just stand in front of my house, in the lawn in front of my house. I have another
00:42:21 risk of being hit by a car. The risk is much greater if I cross the street than if I just
00:42:25 stand on the grass in front of my house. But I cross the street all the time and never get hit.
00:42:31 So still the chances of my being hit are still extremely small, even though I cross the street,
00:42:37 even though the relative risk is much higher, the absolute risk is still very low of being hit by a
00:42:42 car. And I think that's what people don't quite understand.
00:42:45 Yeah. Let's talk about the kind of the elephant in the room today, at least, which is as of
00:42:50 yesterday. And by the time this podcast come out, this might even be irrelevant news. So I don't
00:42:53 want to dwell on it too much. But as of yesterday, the news came out that J&J's vaccine, which as of
00:42:58 this moment has been given to 6.9 million people in the United States, has resulted in six serious
00:43:05 clotting episodes, all in women, interestingly, probably not a coincidence, but it's too soon to tell.
00:43:11 And one of whom has died. So obviously, very easy to believe that these side effects are the result
00:43:19 of the vaccine, given what we saw in the AstraZeneca case. Not clear if it's a coincidence that it's also
00:43:24 in an adenovirus vector. But regardless, let's just think about this for a moment through the numbers.
00:43:31 Six out of 6.9 million people have had a side effect that is completely undesirable,
00:43:38 one of whom has died, which is the ultimate undesirable side effect. But contrast that with
00:43:43 the NNT. Now, the data in the JAMA paper that I looked at, which is where I saw the most robust
00:43:52 data on the vaccine, at least I couldn't extract from it what the NNT was to save a life. Do you know
00:43:59 that? So the NNT data that I quoted, which is about 60, based on the reciprocal of the ARR.
00:44:06 So if you take 100 divided by 1.7, whatever that number is, I'm doing the math in my head,
00:44:12 it's about 60. That's for all reactions. So serious reactions, hospitalizations, death.
00:44:19 But if you just do it on death, I don't know what that is. Do you?
00:44:22 I think it's something like, let's assume just for the purposes of this discussion that
00:44:27 it's roughly one case of this so-called cerebral vascular sinus thrombosis, or blood clot in a vein
00:44:35 of the brain, per million people who got this vaccine. For a million people who would get the
00:44:41 vaccine otherwise, something like 1,850 or so would be prevented from dying. This was presented this
00:44:50 morning. Okay, that's the number I'm asking for. Yeah, what's the difference? So we can do it for
00:44:54 how big that number is will be prevented from going to the hospital. But to actually be prevented from
00:45:00 dying, if it's about 2000, you're talking about a trade-off of 2000 to 1. And that's why I've got
00:45:05 to be honest with you. I looked at the reaction of the federal, if I read it correctly, Paul,
00:45:11 the federal government basically said, we're going to stop this and let states decide. And New York and
00:45:18 California immediately said, we're going to stop it. And again, that's not the worst thing in the world
00:45:22 if we have enough other vaccines in the pipeline to keep going. But my thinking is, that's an
00:45:28 overreactive strategy if it's going to actually prevent people from being vaccinated, isn't it?
00:45:34 Oh, and it's going to prevent people from being vaccinated. I mean, I just think that the minute
00:45:38 you did that, the minute you pause that vaccine, you sent a chill through people in this country.
00:45:45 I think that would affect not only this vaccine, but I think even it would spill over to any COVID vaccine,
00:45:50 which is, I think, what worries me the most about this pause. I mean, I understand why they did it.
00:45:55 I think they wanted to say to people, at the very least, this is an unusual phenomenon. And
00:46:01 typically when you see, for example, thrombotic events, you invariably treat them with heparin,
00:46:05 don't treat this with heparin. So thinking maybe is that intravenous immunoglobulin is the best
00:46:09 treatment, but heparin is the worst thing you could do for this. And so to alert the physicians of that,
00:46:15 also to alert physicians of the fact that if anybody's gotten the J&J vaccine,
00:46:19 and within two weeks of getting that vaccine had signs and symptoms of severe headache,
00:46:23 chest pain, shortness of breath, leg pain, to pay attention to that. I think that all makes sense.
00:46:28 But by pausing it, now the city of Philadelphia is not giving that vaccine anymore. I think in San 0.79
00:46:33 Francisco, they've decided not to give that vaccine. And I just think that the point you
00:46:37 made earlier is exactly right. If it doesn't matter, meaning if we have enough of the Pfizer,
00:46:43 Moderna vaccine, that this is not going to, in any sense, slow our ability to vaccinate this
00:46:47 population and get to the level of population immunity that creates herd immunity, then it's
00:46:52 not that big of a deal. But I think that there's two ways to look at that. One is that we have
00:46:55 enough vaccine that makes it not a problem. But the other thing is that people may now be scared.
00:47:00 That's what scares me the most of this. If you ask me the question, what do I fear most about this
00:47:03 whole pandemic? It's actually not the variants. It's not. It's that there would be a significant
00:47:07 percentage of the population that is going to choose not to vaccinate, so much so that we can't get to
00:47:12 that 80 plus percent of population immunity. We need to slow this virus. And then what do we do?
00:47:17 And we're going to know that by the middle of the summer when we have enough vaccine.
00:47:20 And then we're going to figure out just what percentage of this population doesn't get
00:47:24 vaccinated because it's not small. I mean, I was at the doctor's office yesterday.
00:47:27 The nurse who checked me in told me she was not going to get a vaccine. This is a nurse. You know, 0.70
00:47:32 these are people in the medical profession. So you can imagine what it's going to be like out there
00:47:37 in the real world. And we already know those numbers to some extent. You know,
00:47:39 we know that for example, 46% of Republican men say that they don't want to get a vaccine. 30%
00:47:44 of Christian evangelists say they don't want to get a vaccine. 14% of those in the black community
00:47:49 say they definitely don't want to get a vaccine. So there are groups out there that are going to
00:47:52 be making this choice. We'll see how this plays out. So let's talk about what herd immunity means,
00:47:58 because even something that conceptually makes sense when it comes to the details, we're seeing lots of
00:48:06 experts disagree on what it's going to take to achieve herd immunity. What is your best explanation
00:48:13 for not what it means conceptually, I think we understand that, but for specifically what is
00:48:19 going to be required. And that includes both among children, adults, very susceptible populations.
00:48:26 Like what is it, what does a world look like in which we have herd immunity?
00:48:30 Right. So I define herd immunity for mucosal viruses like rotavirus, for example, as a thing
00:48:36 from non-mucosal virus, systemic viruses, where the virus spreads into the bloodstream like polio and
00:48:42 measles and rubella, where you can eliminate that virus. We're not going to eliminate this virus. I
00:48:46 think the best we can hope for is to significantly slow its spread as we did for rotavirus. I mean,
00:48:51 when the rotavirus vaccine was introduced in the United States, there would be several million cases
00:48:56 every year of rotavirus. There would be about 75,000 hospitalizations and roughly 60 deaths
00:49:01 every year from rotavirus. But no child got to age five without being infected with that virus. That
00:49:04 virus came into the United States in 2006. And within a few years, you started to see a dramatic
00:49:11 drop in the spread of that virus. It's still out there, but it's much, much less. And many residents
00:49:16 have never seen a case of rotavirus-induced diarrhea and dehydration, whereas it dominated my residency.
00:49:22 So you can control it, but you're not going to eliminate it. So I think that's number one.
00:49:27 Number two is, if you look at sort of the contagiousness index and the efficacy of the
00:49:31 vaccine, there's a formula for this. You would figure that you probably would need at least 80%
00:49:36 of the population to be immune, either from natural infection or immunization, to slow the spread of
00:49:41 this virus. But this virus, I think it's going to be with us forever. I don't see it going away. I think
00:49:47 it's just going to slowly get under control, assuming we can get the 194 countries in this
00:49:52 world to get a significant percentage of their population vaccinated. But know this,
00:49:56 we're going to be giving a coronavirus, a SARS-CoV-2 vaccine, continually until it happens
00:50:02 that other countries have gotten it under control. Because, you know, we give a polio vaccine every
00:50:06 year to children in the United States. We haven't had a case of natural polio in this country since
00:50:10 the 1970s. The reason we do that is polio still exists in Pakistan and Afghanistan,
00:50:14 and so international travel is common, so polio could always come back in this country.
00:50:18 And I think that's going to be true here, too. We're going to see how long immunity lasts. We're
00:50:22 going to see whether the variants get to the point where they escape immunity from natural
00:50:26 infection or immunization. But all that is going to play out over years, and we're going to be
00:50:29 dealing with this for years. But I do think we can get control of this virus if we can get at least
00:50:34 80% of the population immune to the point that we can go back to the things we normally do,
00:50:38 like going to Eagles games and screaming and booing without a mask. That is my goal.
00:50:42 Well, as a person who really can't stand the Eagles, you'll have to forgive me that I have
00:50:48 no interest in you going to Eagles games unless you are booing because your team is doing poorly.
00:50:53 Now, that said, let's go back to the person like this nurse who you saw at the doctor's office the 0.99
00:50:58 other day who says, I'm not going to get the vaccine. Now, my view is there's going to be a
00:51:02 subset of the population that will never be convinced that that is the right strategy,
00:51:07 or more to the point that getting a vaccine is a safe alternative to getting COVID. So,
00:51:13 that's fine. I think we do live in a world where medical freedom for adults exists, and I support
00:51:17 that. So, I do support a person's right to choose to not get a vaccine. Can't we still get to herd
00:51:24 immunity when enough healthy people who have refused vaccination survive the infection? Because we
00:51:31 we certainly have seen that natural infection is going to be a great way to develop immunity.
00:51:37 So, I don't know what the numbers are, but is it safe to say about 30% of American adults
00:51:43 don't want to get vaccinated?
00:51:44 I don't know. If I had to guess, I think it's probably that, about 30%, maybe more. And you're
00:51:51 right in terms of natural immunity in that, if you look on the reports, you know, on this COVID
00:51:56 tracker, it says 32,000 people, sorry, 32 million people have been infected with SARS-CoV-2 and have
00:52:02 COVID. But that's only people who've been tested and found to be infected. If you do antibody
00:52:06 surveillance studies, that number is probably all five.
00:52:09 That could be much higher.
00:52:09 It's probably more like the CDC estimate last I saw, which was a few weeks ago, was 85 million.
00:52:14 It's probably close to 100 million people who've been infected with this virus and are naturally
00:52:18 immune. And then we don't know the overlap between those people and then who's been vaccinated.
00:52:22 There's obviously going to be a Venn diagram. You can't add these things up. I guess the way I look
00:52:26 at it is, even with a modest success of the vaccine and those, let's just say those 30% of people
00:52:33 who say, I'm not going to be vaccinated, someone's got to be able to come up with a reasonable
00:52:37 estimate for how many of those people were knowingly infected in the past, were unknowingly
00:52:42 infected in the past. And in other words, those people you could argue don't need a vaccine.
00:52:46 Then you've got the group who have not been infected, who don't want to get vaccinated. Well,
00:52:51 a subset of those people are going to get infected and therefore will develop natural immunity.
00:52:56 For those of us who choose to get vaccinated, Paul, is it really that big a concern at the number
00:53:01 of people who don't want to get vaccinated?
00:53:03 Well, first of all, we're also assuming that natural infection induces a durability and
00:53:08 completeness of protection that is the same as vaccine. That may not be true. I mean,
00:53:12 the vaccine, there are certainly a number of vaccines. The human papillomavirus vaccine is
00:53:15 one example. Tetanus is another. The conjugate Hib and pneumococcal vaccines are another example
00:53:19 where the vaccination is better than natural infection in terms of the immunity that's induced.
00:53:23 That may also be true here. Well, I think it's perfectly reasonable to give them a dose of vaccine,
00:53:28 dose of the mRNA containing vaccines.
00:53:29 Sort of the booster strategy for those who are naturally infected.
00:53:33 You and I are going to differ on one thing, which is a person's right to choose not to be
00:53:37 vaccinated. I think if I cut my foot on a rusty nail, for example, go to the doctor's office,
00:53:42 get it washed out, and the doctor says I would recommend a tetanus vaccine, and I choose not to
00:53:46 get a tetanus vaccine, that only affects me. I mean, if I get tetanus, nobody's going to catch tetanus
00:53:50 for me. That's not true here. I mean, when you make a choice not to get a vaccine, you are making a
00:53:55 choice potentially to catch and transmit a potentially fatal infection. And see, I don't
00:53:59 think that's your choice. I think that should not be your inalienable right as a U.S. citizen
00:54:04 to affect others. I mean, if you're going to stay in your house and the only time you ever
00:54:09 walk outside is you're going to be really good about wearing a mask and making sure you're
00:54:12 four to six feet away from somebody else, great. But that's not the way it's going to play out.
00:54:16 And I think we're dealing with that in our hospital now is the issue of mandating a vaccine.
00:54:20 You know, we have a population of vulnerable hospitalized children. Certainly viruses like
00:54:25 this can spread in a hospital. And is it your responsibility as someone who works in a hospital
00:54:30 in a group of vulnerable hospitalized children to get a vaccine? We think the answer is yes.
00:54:34 Well, I would agree with you on that. So I mean, obviously, these things are nuanced. I'll tell you
00:54:37 where my view is. There are going to be some people for whom there is a privilege that comes from
00:54:43 your existence. So for me, healthcare is a privilege. To be a doctor or a nurse is a privilege, not a right.
00:54:50 And so I would agree with you. If you're going to work in a hospital and take care of patients,
00:54:54 I do not believe you should have the right to refuse vaccination for exactly the reasons you've
00:54:59 stated. Furthermore, I would agree that, and this is getting way off topic, but when it comes to MMR,
00:55:05 I don't think the parents should be able to refuse that for their child because I don't think it's
00:55:10 fair to the children. In other words, I don't think a parent should be able to make a decision
00:55:14 that's going to negatively impact a child. I will go one step further. This is going to,
00:55:19 I'm sure make, I'm sure every statement I'm making is making a newer and newer faction of people
00:55:24 irate. So the last one I'll say is, I think that society may have to make decisions about who
00:55:30 can and can't have other certain privileges such as travel. So I think that there should be a day when
00:55:38 if we decide, you know what, like people who haven't been vaccinated or haven't conferred natural 0.96
00:55:42 immunity through some other means and can demonstrate it, maybe we don't want to have all those people
00:55:47 traveling on airplanes or maybe certain countries are going to say you can't enter unless you've
00:55:52 done those things. So I think you and I would probably be aligned on everything I just said.
00:55:56 I think where we do differ is if John Smith, who works in whatever he does, doesn't want to get
00:56:04 vaccinated provided his society, his network is okay with that, you know, and he's not lying about
00:56:12 it or something, which again, I think there are ways around that. You have to live with the consequences
00:56:16 of your choice. When people say to me, why would you, Peter, as a healthy, you know, roughly 50 year
00:56:23 old get vaccinated when your odds of dying are so low from a natural infection? I say, frankly, my concern
00:56:30 is not death. I think my odds of dying from this virus are so low that, you know, I'm more,
00:56:36 I'm much more afraid of dying in a car accident. What I'm afraid of are the long-term consequences
00:56:41 of this that don't seem trivial, even in young people. And, you know, there was an article in
00:56:46 JAMA maybe two months ago that talked about some of the long-term neuropsychiatric complications that
00:56:52 are being seen in up to a quarter of people six and 12 months out. And to me, those are the things
00:56:58 that are of grave concern. And again, when you weigh the risk of that versus the risk of vaccination,
00:57:04 which I think you very eloquently spoke to at the outset, to me, it's personally a no brainer.
00:57:10 But that said, there are gray areas in between. That said, of course, I agree with you about in
00:57:16 the hospital. I think it's a tragedy that a high risk patient would be cared for by someone in a
00:57:20 hospital who has willingly or knowingly chosen not to be vaccinated. This is probably the one area
00:57:25 we're going to disagree. But I think, see, I see the hospital as a microcosm of society. I mean,
00:57:29 if I, there are probably about 500,000 people or so in this country who can't be vaccinated because
00:57:34 they're getting biologicals for their chronic disease, because they're getting chemotherapy for their
00:57:38 cancers, they depend on those around them to protect them. I mean, I remember when, when
00:57:43 California suffered its measles epidemic and Richard Pan, who was a democratic state senator
00:57:48 out of Sacramento, basically eliminated the philosophical exemption, leaving California
00:57:53 with only medical exemptions. They'd never had a religious exemption. Now that you only had
00:57:57 medical exemptions, if you went to school in California, you had to be vaccinated or you could
00:58:01 homeschool. There was a little boy who showed up at those meetings and certainly the anti-vaccine
00:58:05 folks were all over those meetings. They didn't want this, this exemption eliminated. And this,
00:58:10 he was great. I just wish there was a videotape of him because I've heard what he said and I've
00:58:14 seen pictures of him, but he's a little kid named Luke who was five years old and he was in the
00:58:19 induction phase of his chemotherapy for acute lymphoplastic leukemia. And he would get up to
00:58:23 the microphone. They'd have to give him a stool so he could reach the microphone. And he would say,
00:58:27 what about me? I depend on you to protect me. Don't I count? And I think that that's how I see,
00:58:33 I see the hospital in some ways as society, you know, you don't know who you're running into when
00:58:37 you're getting on a subway or a bus or whatever. And that could be, those could be the Luke's out
00:58:41 there. So I just don't think if it's, it's a contagious disease that that's, that's where I
00:58:45 sort of draw the line. So love to discuss this more over a meal. Let's talk about the implication
00:58:52 of it though. Do we believe, cause I don't think it's going to happen from a practicality
00:58:57 standpoint. Is there any chance this is going to be mandated? At the private level, there's already
00:59:02 is at some level and in a carrot, not stick sort of way where, you know, a number of universities now
00:59:07 said, want to come back to campus. Great. Love to have you get vaccinated. If not, you're going to
00:59:10 continue to do remotely. Sure. And just as travel restrictions may only open up to those who are
00:59:17 vaccinated. I mean, I completely, I think that's exactly the right way to do it. But my point 0.99
00:59:22 is we'll never do what California did, which is say, you don't get to send a kid to school without
00:59:27 vaccination, which by the way, I think was the right thing to do a hundred percent,
00:59:30 but I don't see how you would enforce or make something like that happen in society. So assuming
00:59:35 we don't, what do you think is the duration of time from now until we achieve herd immunity,
00:59:42 based on what you know about the speed with which the vaccines are rolling out and the limited
00:59:47 information we have about the rates of natural infections, which are obviously challenging to
00:59:52 comprehend. Right. So let's assume the following. Let's assume that about 25 or maybe as many as 30
00:59:58 percent of the population has been naturally infected. We know that about 22 to 23 percent
01:00:04 of the general population has also been now fully vaccinated. With the adult population,
01:00:09 so it may be a little more than that. And you're right, there's overlap in terms of having been
01:00:13 infected or having been vaccinated. So let's assume we're getting close to 40 percent. To get to 80
01:00:18 percent, you're probably going to need to fully immunize another 120 million people. We're vaccinating
01:00:23 more than three million people or three million doses of vaccine a day. These are mostly two-dose
01:00:27 vaccines. So if you just play out the math, it's possible that if we continue to get three million
01:00:33 doses a day out there, that within three or four months, we could have vaccinated that other 120
01:00:38 million people. I think by mid-summer, when there's enough vaccine for everybody, that's when you're
01:00:42 going to really find out how many, what percentage of the population doesn't want to get vaccinated.
01:00:46 And then we'll see what we're going to do. And the way that you'll test, you'll know whether or not
01:00:50 we've succeeded with herd immunity is what happens next winter. This is still at its heart, largely a
01:00:54 winter respiratory virus. And if you look at what happened when the virus came into the U.S. in early
01:00:58 March and started to kill people, it quickly shot up. You would have 2,000, 2,500 deaths. So just
01:01:03 look at deaths, deaths a day. And then it started to come down. As you went to sort of April, May, June,
01:01:08 you started to see the number of deaths per day come down. This was in a wholly susceptible
01:01:13 population without a vaccine. And then for the summer months, you were sort of at hundreds of
01:01:18 deaths a day. Then once you hit November, December, it took off again. 2,000 deaths a day, 3,000 deaths
01:01:23 a day, 4,000 deaths a day, 4,500 deaths a day. And then now it's started to come down again. And I
01:01:29 think that there's several reasons. One, because a larger percentage of the population is immune from
01:01:33 natural infection because a larger percentage of the population is immune now with vaccination. But
01:01:36 I think also the weather has something to do with this. So it's now starting to come down. What
01:01:41 happens then next winter, if we're at population immunity that is effective, then you will see a
01:01:47 bump in the winter month. If we're not, you are going to see a surge just like we saw this winter
01:01:51 in the winter month. And that's how you'll know. But we're going to be vaccinating this population 0.80
01:01:56 for my lifetime because I just think this is a virus that's not going to go away. We're going to
01:02:01 continue to need to keep up that population that's immune. And that's also going to involve
01:02:05 children. So now, you know, we've got an approved vaccine down to 12 years of age. I think by early
01:02:10 next year, we'll probably have it down to six years of age. And then we're going to need to,
01:02:14 I think, vaccinate children as well. Will that be because children are vectors 1.00
01:02:18 or because we actually fear harm to the kids themselves? Both. But I was on service for two weeks in
01:02:25 a row about a week ago. And it's the same thing that you mentioned earlier in terms of like
01:02:31 fear of long-term disease. You should see what MIS-C looks like up close. I mean,
01:02:35 this so-called multi-system inflammatory disease in children, which is not uncommon. And they all
01:02:40 tell the same story, a very similar story, which is that they had an incidental infection,
01:02:45 something that was picked up often because a family member or friend got sick. And so then they
01:02:49 had, they were tested to be PCR positive, but were asymptomatic. A month later, they come now to our
01:02:53 house with high fever, involvement of heart, liver, lung, kidney, you know, heart enzymes spilling
01:02:58 out into the bloodstream with high fever. And they're PCR negative and they're antibody positive.
01:03:04 I mean, their immune system has been induced to make an inflammatory response against themselves.
01:03:09 I mean, primarily against the cells that line vessels. And so this is a largely a vasculitis.
01:03:14 And because every organ in your body has a blood supply, virtually every organ can be affected.
01:03:18 It's pretty frightening to see. And do I think that some of these kids are going to have long-term
01:03:22 problems? I absolutely do, for the same reason Kawasaki's did that. I mean, 0.99
01:03:26 also another multi-system inflammatory disease that could cause long-term heart problems. I think
01:03:31 that is likely to be true here. We're going to learn as we go. But if a parent sat across from me
01:03:36 in my office and asked me, why should I vaccinate my child? These are the stories I would tell,
01:03:41 the Miss C story. Yeah. I mean, I wish I had a crystal 1.00
01:03:44 ball that would show us the data we're going to have a year from now. Like when you think about how
01:03:48 much we have learned in 12 months, it has been a geometric outflow of knowledge. And the next 12
01:03:53 months will offer, I think, even more insight. Because as you said, we're going to be laying
01:03:59 over the natural infection. The vaccine immunology will also, as you basically alluded to, really
01:04:06 have a true sense of what steady state is going to look like societally with respect to vaccine
01:04:11 refusal. And so we will be able to incorporate that into models of how close we are going to get
01:04:17 to that herd immunity. But let's talk about it through the two scenarios. There's a scenario clearly
01:04:21 where enough people refuse vaccination that we never truly achieve herd immunity.
01:04:26 And in that sense, the real tragedy is for the vulnerable people who can't be immunized,
01:04:30 correct? I mean, I think that's a very clear thing to acknowledge is there's going to be a subset of
01:04:35 people who, because of their cancer treatment or rheumatologic treatments, can't be vaccinated.
01:04:40 And the disease is still spreading like crazy. Then there's a scenario under which we get to herd immunity
01:04:46 on the backs of people who are naturally infected and or are willing to be vaccinated, inclusive of
01:04:53 children. And have you done the math on how far down you need to go in kids' ages to almost assure
01:04:59 that happens? In other words, if you go down to six years of age, is that pretty much a fait accompli?
01:05:05 Oh, for sure. You may not even have to get down that far. I mean, it's something like 20% of the
01:05:10 population is less than 18 years of age. So you assume that all adults got vaccinated, which isn't
01:05:15 going to happen. You know, you're already talking about 80%. But the other reason I think that deaths
01:05:20 are down, you look at Michigan, for example, clearly there's been a surge of cases in Michigan,
01:05:23 but not really a surge in deaths. And I think the reason is, is that it's something like 55% or 57%
01:05:29 of people over 65 now have been vaccinated fully and something 75% have gotten at least one dose of
01:05:34 vaccine. So we're starting to pull out of the group, the group, those that are most likely to die.
01:05:40 It's something like 92% of those over 55 or those over 55 account for 92% of the deaths.
01:05:46 So, you know, we're now pulling them out. And so that's, I think it's one of the several reasons
01:05:51 why the deaths are clearly coming down now. Paul, how long do you think it'll be before we
01:05:55 know the frequency with which people need to be given a booster shot? And is this going to be a
01:06:01 single booster shot that should be more than enough to make sure that the memory T and B cells are
01:06:08 rocking and rolling? Or do you think that, and by the way, I'm putting aside for a moment,
01:06:12 mutation. So let's put that aside for one second, but just on the basis of B117, D614,
01:06:21 is it your immunologic expectation that if you've had your two RNAs, you'll need one more. If you've
01:06:28 had your one ad, no, you'll need one more and that should be it. Or is it, are we talking about
01:06:33 an annual or biannual process? I think we'll know in two years. I think we'll have a much
01:06:37 better idea in two years how this plays out. There were studies done with human coronaviruses,
01:06:41 human challenge studies done with human coronaviruses in the early 1990s, where they
01:06:45 would, you know, someone would be infected with a serotype, one of the four serotypes of human
01:06:48 coronavirus that circulates. And then a year later, they were experimentally challenged with that virus
01:06:53 to see, answer the question, were they protected against symptoms associated with illness? And they were
01:06:58 a year later, but they never did those studies beyond that. I'm optimistic that it would be for
01:07:04 a few years, but I don't think that we're talking about decades. Okay. Let's pivot to another question
01:07:10 that has come up a lot. And when it first arose, which was a year ago, if not more than a year ago,
01:07:17 the people who were raising it sounded crazy. And today it doesn't sound so crazy, which is the
01:07:23 origin of this virus. So there are largely two competing theories. The first is the theory that
01:07:28 was proposed at the time of the pandemic's arrival, which is that this was a virus that escaped from
01:07:37 a bat or left a species of a bat via some intermediary mammal and made its way to humans.
01:07:43 This originated in a wet market in China. And that's kind of the story everybody knows. But with
01:07:50 increasing, I don't want to say veracity, but certainly with more and more reason behind it,
01:07:57 there are lots of people offering explanations for the idea that this was actually an accidental
01:08:02 escape of a virus in a lab that happened to be near Wuhan. So I guess there were three labs near
01:08:09 Wuhan that would do this type of research. This theory does not suggest biological warfare,
01:08:14 that this was deliberately unleashed, but rather that any lab can have a breach in
01:08:19 protocol that could result in a virus leaving. How much have you examined this theory?
01:08:24 I mean, certainly it is not unheard of that laboratories have done so-called gain-of-function
01:08:28 studies to see what would happen if they alter a virus and then cause it to be able to do things
01:08:34 it couldn't do before. So for example, you could take rabies virus. I'm not saying you should do
01:08:39 this or how easy it would be to do this, but you take rabies virus, which is essentially a universally
01:08:43 fatal virus, but not easily transmitted. I mean, in order to get rabies virus, you usually have to be
01:08:48 bitten by a rabid animal and make it such that it is spread by the respiratory route. So now you have
01:08:54 a contagious virus that is highly fatal, which I think was basically the story behind the movie
01:08:59 Contagion. I think it was a Nipah virus that killed Gwyneth Paltrow in that movie and others,
01:09:05 because they showed an electron micrograph of it. And I think this was a Nipah virus, which is
01:09:11 not easily transmitted. And they made it easily transmitted. It's something that affects the brain,
01:09:15 they made it easier. So certainly gain-of-function studies have been done. Is it possible that
01:09:20 somebody in Wuhan was doing these kinds of gain-of-function studies? I'm telling you,
01:09:24 though, this is like the world's smartest human. I honestly don't think humans were smart enough to
01:09:28 make this virus, given all the things that it can do. The only way to really know the answer to the
01:09:32 question, because I think this is a knowable question, is to go back and look at all the
01:09:37 sequences of those early strains and go back as early as you can and look at, you know,
01:09:41 CIRA from people in China, you know, from well before this virus was said to have spread. I mean,
01:09:47 think about it. We really depended on a whistleblower in Wuhan to tell us what was going on,
01:09:52 which was China not acting like a good neighbor here. And that's the way we did it with HIV. I 0.97
01:09:57 mean, when we finally got all the sequences that we needed with HIV, we'd go back further and further
01:10:02 and further to see when exactly it evolved from so-called simian immunodeficiency virus. I mean,
01:10:08 the chimp virus. You could see that it happened in Cameroon in the 1930s, presumably when a hunter
01:10:14 cut the chimp and then cut himself and introduced the virus into himself. But so it's knowable. I 1.00
01:10:19 just don't think we know. So now we're left with sort of postulates as to how it happened. My bias
01:10:24 is that it jumped from a bat to humans, presumably from an intermediate host that remains unidentified.
01:10:30 You know, people have suggested maybe it's pangolins, but that's knowable if we can just have all 0.99
01:10:34 the sequence data we need. And China has not been great about opening its doors and letting us see
01:10:39 all that information. If you assume that it occurred naturally, it begs the question,
01:10:48 if versus when this occurs again, because coronaviruses have been around longer than we have.
01:10:55 There's no reason to believe that SARS-CoV-2 is the last of them. So what is the implication for SARS-CoV-3?
01:11:04 Oh, we can assume this is going to happen. I mean, you know, we had SARS-1, which was largely
01:11:08 a bat virus. We had MERS, which came out of Saudi Arabia, which was also at least in part of bat
01:11:13 virus. And now you have, you know, SARS-CoV-2, three viruses all within roughly 20 years, right?
01:11:18 SARS-1 was around 2002, MERS around 2012. It'll happen. I mean, I'd like to think what we've learned 0.78
01:11:25 from this is that it will happen, that we need a level of international collaboration, that with the
01:11:31 minute there's evidence that this is going on, that there's an international surveillance system
01:11:35 where all countries are open to this, where we can identify it, you know, do the kinds of works we
01:11:41 need to do, not just to make a vaccine, but to have, you know, personal protective equipment
01:11:44 and ventilators or anything else that you're going to need so that we're not overwhelmed by this.
01:11:49 I mean, this, unless you're 130 or 140 years old and lived through the 1918, 1919 flu pandemic,
01:11:54 no one has lived through this. And I'd like to think this has sobered us up as to what needs to
01:11:59 be done moving forward. Do you think that there's a chance that if the next variant of this comes
01:12:05 along, which is even worse than this one, so pick, so either it's more virulent, but has the same degree
01:12:11 of transmissibility, or it's similar virulence, but an even greater transmissibility, either of those
01:12:16 would make for a much worse pandemic. Do you think that there's a chance that such a virus emerges,
01:12:22 let's just say it originates in the United States, that a given population locally could be shut down
01:12:28 enough to identify quickly patient zero, you know, the first 50 people, and immediately quell this
01:12:35 thing? Or do these types of things never result in a local shutdown that is effective and they will
01:12:43 always turn into something bigger? Because the difference between SARS-1 and MERS is not so much
01:12:49 that the response was amazing. I mean, in the case of MERS, I think the thing was just such a deadly
01:12:54 virus that it didn't have a high enough reproductive rate because it was killing people too quickly. 0.99
01:12:58 It's not like we did such a great job with those viruses. It was really the biology of the viruses,
01:13:04 right? Right. I think both SARS-1 and MERS were, did not have this level of asymptomatic
01:13:09 transmission. I think that's what makes this virus so awful. And that when you walk past somebody in 0.91
01:13:14 the street who's perfectly fine, they could be shedding this virus. That really wasn't true
01:13:18 with SARS-1 or MERS where most of that disease was either moderate or severe. So it was much easier
01:13:23 to put a moat around those infections than you can here because everyone could be infected. This
01:13:27 actually in many ways reminds me of polio. I mean, I am a child of the 50s. I'm much older than you are,
01:13:32 but I remember polio. But part of the heinousness of polio was that only about one of every 200
01:13:36 people who was infected with polio virus was paralyzed. I mean, there was a lot of asymptomatic
01:13:40 transmission of that virus. So what does that mean though,
01:13:42 Paul? How confident are you that 10 years from now, we're not going to have another worldwide
01:13:47 pandemic that, you know, the analogy I used to describe this to somebody the other day was,
01:13:53 when you're driving a race car, the worst thing you can be doing is braking too late because then
01:13:59 you have to brake much harder than you want to. And the dynamics of the car become really unstable
01:14:04 and you're probably going to crash. And in some ways, I sort of feel like that's what happened
01:14:09 in the United States, which is we didn't brake soon enough. And when we did brake,
01:14:15 we had to brake way harder than we should have, and we crashed. And I want to believe we could learn
01:14:21 from that. For such a great analogy. I do think that at the heart of that question is how much do I have
01:14:27 faith in human nature that we can learn from these things, that we will have the kind of heart,
01:14:33 big heartedness that will allow us to have international collaborations and more open
01:14:37 borders regarding sort of scientific inquiry. We haven't been very good at that so far. If we
01:14:42 don't learn our lesson here, I mean, we're never going to learn it. So I don't know. I don't have
01:14:46 an enormous amount of faith in human nature that we're going to learn from this, but I hope you're
01:14:50 right. Yeah. I wasn't suggesting I was right. I was just, I was wondering what would need to happen,
01:14:55 right? What would, let me pose it to you this way, Paul. If someone came to you and said,
01:15:02 hey, I want to put you in charge of thinking about the next pandemic. You're doing a great job
01:15:07 helping us with this one, but we've got a lot of people thinking about this one. I want you to go
01:15:11 on vacation for two weeks, recharge, shake the dust off a little bit, and I want you to come back.
01:15:17 And the only thing I want you to do is think about how we're going to prepare for the next one.
01:15:21 What would be some of the ideas you'd put forth? It's an international collaboration. That's an
01:15:25 international question. So you have to get the governments and the scientists from every nation
01:15:30 in this world in line with what are we going to do collectively to monitor for the next pandemic
01:15:36 potential virus. And there will be a next pandemic potential virus in terms of surveillance. How are we
01:15:41 going to do that? How are we going to do the sequencing? Who's going to do it? And then once in
01:15:45 hand, when we see that that's true, how are we going to collaborate to do this to make sure we all
01:15:50 have what we need because we're all dependent on each other, because we're only as strong as our
01:15:54 weakest nation out there? How are we going to do that? But even with the vaccines, you see a
01:15:58 certain level of nationalism, right? The Chinese have their vaccines, the Russians have their vaccines,
01:16:04 we have our vaccines. The fact of the matter is, I think Dr. Fauci is amazing. He's a phenomenal
01:16:10 science communicator. He's a brilliant man. The only time he's ever said anything that bummed me out a
01:16:16 little bit was when somebody asked him about whether or not there would be another vaccine
01:16:20 that would be submitted for licensure, like the UK AstraZeneca vaccine being submitted for
01:16:24 UA approval here. And his response to that was, we don't need another vaccine. We have enough
01:16:28 vaccine for our country. But I think our country has a responsibility to all countries in this world,
01:16:33 who are economically and technologically advanced, to provide vaccine for everyone if we can. And we can.
01:16:38 You know, the Pfizer, look at these mRNA vaccines. They're given at 30 micrograms or 100
01:16:43 micrograms a dose. A microgram is a millionth of a gram. That's 10 to the minus six, right?
01:16:48 You can make kilograms. That's 10 to the third, right? That's a nine log difference. That's a
01:16:53 billion fold difference. Can you make billions of doses of mRNA vaccine? Absolutely. Should you?
01:16:58 Absolutely. And if it means restricting sort of the intellectual property and allowing that to happen,
01:17:04 it should happen because it's the right thing to do for these companies and for the world.
01:17:09 So this is an unrelated question to where I want to go. But while we're here on the topic,
01:17:14 do you have any idea what vaccine hesitancy rates are like outside of the United States? I have
01:17:18 actually haven't looked at those data. Right. So there's a woman named Heidi Larson
01:17:22 at the London School of Public Health who does this. She has something called a vaccine confidence
01:17:27 project. So she goes throughout countries in this world to see sort of what she measures vaccine
01:17:32 confidence. She recently had a book out that came out called Stuck. But interestingly,
01:17:36 we're not the least confident country in this world. The least confident country in this world
01:17:41 for vaccinations is France. Don't know why. Yeah, France is number one. So we're not actually
01:17:48 that bad. But see, I sort of divide this into two categories. I think there's the skeptics and I'm a
01:17:54 skeptic. I think you should be skeptical of anything you put in your body. I think you should want to see
01:17:57 the data to make sure that what you're being given has been adequately tested and vetted. I think
01:18:03 skepticism at this point, certainly for the mRNA vaccine, should melt away. You've got a highly
01:18:08 effective vaccine that doesn't even appear to have a rare serious side effect problem,
01:18:12 and it's been in 120 million people in the United States. Skepticism should be gone. And I think
01:18:16 largely among that group, it has. When you look at sort of percentage of people who said they would
01:18:21 definitely get a vaccine, they say last September, it was about 30 percent. Then by December, it was 40
01:18:26 percent. The University of Washington came out with recently a survey that suggested it's about 70
01:18:31 percent that said they would definitely get a vaccine. And then there's the second group,
01:18:35 which are the vaccine cynics. And they just don't trust the government or trust pharmaceutical
01:18:40 companies or trust the medical community. They just don't believe you. They don't believe you.
01:18:44 It's amazing to me that some of those people are also in the medical profession,
01:18:47 but that's been the experience. So you can't convince them. Neil deGrasse Tyson has just a great
01:18:53 quote on this, which is, if people don't use reason or logic to come to a specific conclusion,
01:18:57 reason and logic are not going to talk them out of it. So then what do you do? And then this is what
01:19:01 we were talking about earlier. Do you compel them either with the carrot or the stick to get
01:19:06 vaccinated because what they do affects others? When I think back, looking at the past year,
01:19:10 Paul, this is my opinion, which I'm only stating so you can contrast it with something that's probably
01:19:15 much more thoughtful. My view of the greatest single failure in the past year was how long it took to
01:19:21 get testing up and running. When I think about the absolute buffoonery on the part of, I think it
01:19:30 was frankly, mostly on the part of the government, but I'm sure there were others at hand. It was the
01:19:36 inability to make testing readily available. Now, I don't think it was at the obvious level. I mean,
01:19:42 I think there are things that probably weren't in place. In other words, how much reagent existed for
01:19:48 PCR to begin with? But you'd like to think that in a future pandemic or in preparedness for a future
01:19:54 pandemic, you would have enough PCR machines, you would have enough reagent, you would have enough
01:20:00 other critical infrastructure such that the moment you had a sequence, because getting the sequence of
01:20:06 this virus was not the right limiting step. The moment you had a sequence, you would be able to
01:20:11 rapidly deploy tests to contain this thing. And I think a lot of the things that have happened since
01:20:18 that time have been actually pretty good. Like, I mean, the speed with which the vaccine has been
01:20:22 developed has been remarkable. I think the evolution of insight into critical care has actually been
01:20:28 pretty darn impressive. So I think a lot of things have gone kind of well, but boy, that testing thing
01:20:35 is really what goes back to my analogy of coming, you know, waiting way too deep in the corner to hit the
01:20:40 brakes and then slamming on the brakes and crashing the car. What's your assessment of where we really
01:20:49 lost things this time around and therefore where we'd want to really make sure we had it right the
01:20:53 next time around? Right. I completely agree with you. I mean, we had the sequence in hand by January
01:20:58 of 2020. The virus started to kill people in this country two months later. Was that enough time to be
01:21:03 able to create, produce, and distribute enough tests that we could have done what South Korea did? Now,
01:21:08 we're not South Korea in many ways. I think we are a much more diverse population that is much less 1.00
01:21:15 corrallable, if you will. And so, but I do think that we put all our eggs in the CDC basket. It was
01:21:21 just CDC that was making the test, whereas it should have been many, many groups that were making those
01:21:25 tests initially and quality controlling for them. Because what happened was then CDC screwed up.
01:21:30 They did. They screwed up the testing so that their negative control ended up being positive.
01:21:34 Therefore, those tests were useless. And so, by the time that all got sorted out,
01:21:38 South Korea had done 500,000 tests when we had done fewer than 5,000. It was pathetic, 0.91
01:21:43 pathetic. And if we had done that, and again, I just don't think we didn't have great federal 0.99
01:21:48 leadership either. That's today's understatement in terms of this, where you could have said,
01:21:52 let's get things in place to do the testing, do the quarantining, do the restriction of international
01:21:57 travel that would have allowed us to be much better off. I mean, we are roughly,
01:22:01 roughly at 4% of the world's population and 20% of the world's deaths when we have a technologically
01:22:06 and economically advanced society. So there's really no excuse for doing it as badly as we did
01:22:12 it. But I think the testing was one big reason. I agree. Well, Paul, there are actually several
01:22:16 things I want to talk with you about more, but I also know that given that the news of J&J's vaccine
01:22:22 just hit, you are probably being dragged in a million different directions. So I want to let you
01:22:28 get on with those obligations. And I'm incredibly grateful that you made time to still speak with me
01:22:34 today, obviously far less important than speaking with all the other people that are clamoring at
01:22:38 your door today. So thank you again for making time as it was the case last time, just a phenomenally
01:22:44 interesting discussion to me. I learned a lot and I know that the folks watching this did as well.
01:22:48 Well, no, thank you. I can tell you that you'll be the most interesting,
01:22:51 smartest person that was clamoring at my door as I go through the rest of my day. But no,
01:22:55 I really appreciate this. It was a lot of fun. Thank you. Thank you for listening to this week's
01:22:58 episode of The Drive. If you're interested in diving deeper into any topics we discuss,
01:23:03 we've created a membership program that allows us to bring you more in-depth exclusive content
01:23:08 without relying on paid ads. It's our goal to ensure members get back much more than the price
01:23:13 of the subscription. Now to that end, membership benefits include a bunch of things. One, totally kick-ass
01:23:19 comprehensive podcast show notes that detail every topic, paper, person, thing we discuss on each
01:23:24 episode. The word on the street is nobody's show notes rival these monthly AMA episodes or ask me
01:23:31 anything episodes, hearing these episodes completely access to our private podcast feed that allows you
01:23:36 to hear everything without having to listen to spiels like this, the qualities, which are a super short
01:23:42 podcast that we release every Tuesday through Friday, highlighting the best questions, topics,
01:23:47 and tactics discussed on previous episodes of The Drive. This is a great way to catch up on previous
01:23:52 episodes without having to go back and necessarily listen to everyone. Steep discounts on products
01:23:58 that I believe in, but for which I'm not getting paid to endorse, and a whole bunch of other benefits
01:24:03 that we continue to trickle in as time goes on. If you want to learn more and access these member-only
01:24:08 benefits, you can head over to peteratiamd.com forward slash subscribe. You can find me on Twitter,
01:24:14 Instagram, and Facebook, all with the ID peteratiamd. You can also leave us a review on Apple Podcasts or
01:24:21 whatever podcast player you listen on. This podcast is for general informational purposes only and does not
01:24:27 constitute the practice of medicine, nursing, or other professional healthcare services, including the giving
01:24:33 of medical advice. No doctor-patient relationship is formed. The use of this information and the materials
01:24:39 linked to this podcast is at the user's own risk. The content on this podcast is not intended to be
01:24:46 a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard
01:24:52 or delay in obtaining medical advice from any medical condition they have, and they should seek
01:24:58 the assistance of their healthcare professionals for any such conditions. Finally, I take conflicts of
01:25:04 interest very seriously. For all of my disclosures and the companies I invest in or advise, please visit
01:25:10 peteratiamd.com forward slash about where I keep an up-to-date and active list of such companies.
01:25:34 Thank you.